Pharmaceutical Business Review
Anonymous User | Login

Bikam, Dalton Renew, Expand Research Agreement

Published: 29-Oct-2009

To discover and develop new ophthalmology therapeutics

Bikam and Dalton Medicinal Chemistry (Dalton) have renewed their exclusive worldwide collaboration to discover and develop new ophthalmology therapeutics.

As per the renewed agreement, Dalton will continue to utilise its proprietary insights to advance several novel classes of compounds against selected Bikam targets. Bikam will advance these agents with its growing battery of biological assays and delivery methodologies.

David Garvey, Vice president of Chemistry at Bikam, said: “For the past 18 months we have had a very productive relationship with the Dalton Medicinal Chemistry team."

Judd Berman, co-founder of Dalton, said: “It’s been exceptionally exciting to work with the talented scientists at B ikam to advance these important programs towards clinical development and beyond. We are delighted to have the opportunity to further contribute to these pioneering programs.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Valsynthese

Hazardous Chemistry in Safe Hands ...

USB

Products from Affymetrix ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

TAPI

A Leading Global Supplier of Active Pharmaceutical Ingredients ...

Pharma IQ

Workshops, Conferences and Training Courses for Pharmaceutical Professionals ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

No items to display

Suppliers Product News

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community

Thomson Reuters Announces the Availabilty of Three Pharma Matters Reports Covering January - March 2009

Quarterly Reports Use Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments in the Global Pharmaceutical Industry

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address